Concepedia
Statistics
Publications
31
Citations
1.9K
H-Index
24
Active since
1998
Affiliations
Janssen (United States)(Current)
Janssen Scientific Affairs (United States)
Group for Research in Decision Analysis
University of Connecticut
Janssen (Belgium)
Jeffrey Schein is an author at Janssen (United States) specializing in pharmacotherapy, medicine, and clinical pharmacology.
Publications per year
1998–2024
Reducing clozapine-related morbidity and mortality: 5 years of experience with the Clozaril National Registry.
Gilbert Honigfeld, Félix Arellano, Jitender Sethi et al. · PubMed · 1998 · 220 citations
Pharmacy, Pharmacology, Pharmacotherapy +17
Influence of Low HDL on Progression of Coronary Artery Disease and Response to Fluvastatin Therapy
Christie M. Ballantyne, J. Alan Herd, Laura Ferlic et al. · Circulation · 1999 · 198 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +17
Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients
François Laliberté, Michel Cloutier, Winnie W. Nelson et al. · Current Medical Research and Opinion · 2014 · 185 citations
Medicine, Cardiology, Pharmacotherapy +17
Clinic visits and hospital admissions for care of acid-related upper gastrointestinal disorders in women using alendronate for osteoporosis.
Bruce Ettinger, Alice Pressman, Jeffrey Schein · PubMed · 1998 · 134 citations
Medicine, Internal Medicine, Pharmacotherapy +11
Epidemiology, microbiology and outcomes of healthcare-associated and community-acquired bacteremia: A multicenter cohort study
Marin H. Kollef, Marya D. Zilberberg, Andrew F. Shorr et al. · Journal of Infection · 2010 · 97 citations
Life Sciences, Infectious Diseases, Microbiology +14
1–5 of 31